Under the general direction of the Senior Scientist or designee, the Supervisor is responsible for all of the day-to-day technical and administrative activities of the molecular laboratory within the newborn screening program. Supervises all technical processes related to the molecular laboratory's testing of newborns, from specimen receipt through analysis with validated protocols and documentation of testing. Develops, evaluates and implements new DNA- or RNA-based methodologies to improve current screening, as well as add new capabilities. Implements quality assurance and safety activities inclusive of written protocols, selection of appropriate equipment and instrumentation, LIMS relationships, employee training, competency assessment, operations improvement, and proficiency testing. Serves as a significant expertise resource to the Newborn Screening Program (bringing new information and technology into the Program from outside sources, by reading and evaluating literature, and networking with colleagues), and independently contribute to development of molecular technologies applicable to our high throughput screening services.
REQUIRED EDUCATION
Master’s degree in chemical, life or clinical sciences; or equivalent
Graduate-level coursework yielding expertise in the theory of general molecular biology
REQUIRED WORK EXPERIENCE
5 – 7 years of relevant experience including at least 1-2 years in a clinical laboratory
5 – 7 years of Assay Design, Implementation and Troubleshooting
In-depth experience and expertise in Primer Design, Probe Design, LNA design, Multiplex RealTime PCR design, Nested PCR design, copy-number assay design such that the supervisor is a recognized expert in the following:
• clinical development and application of PCR-based assays, inclusive of the prevention and containment of amplicon contaminants,
• the development and implementation of clinical detection systems for the generation of human genotypic data using a variety of techniques (Luminex Lab developed tests, Real-Time lab developed tests), and
• the development and implementation of clinical assays for the evaluation of the presence/absence and quantification of molecular markers (RealTime and Digital Droplet PCR or equivalent), such that the development yields low-cost laboratory developed tests.
5 – 7 years of Development of High-throughput Clinical Molecular Assays
• Expert-level practical experience in the isolation of nucleic acids from small-volume (3 µL) dried blood spots or other similar human specimens.
• Expert-level practical experience with high-throughput processing of clinical specimens (e.g. integrated flow chart development)
• Expert -level practical experience with robotics programming for high-throughput processing of clinical specimens
3 – 5 years of experience with BLAST and gene homology tools available through NIH and commercial vendors
3 – 5 years of experience with database and spreadsheet tools for use with quality monitoring and data management
3 – 5 years of experience with Sanger sequencing and related informatics
1 – 2 years of sufficient familiarity with Next Gen Sequencing theory to maximize efficiencies of high-throughput screening assays to be interfaced with NextGen sequencing.
Must satisfy CLIA requirements for high complexity testing
Skilled in the knowledge, performance, and interpretation of lab tests and techniques
Skilled in computer file management and general software usage
Communications and writing skills for scientific reports, oral presentations, SOPs, internal communications
Skilled in clear communications and maintenance of good working relationships with co-workers
Flexibility in work schedule as required by laboratory section (i.e. weekend and holiday rotations).
PREFERRED WORK EXPERIENCE
Previous supervisory experience
A thorough understanding of regulatory issues (e.g. CLIA, OSHA) as they apply to clinical laboratory testing
Practical knowledge of human molecular genetics
Software Powered by iCIMS
www.icims.com